Figure 1. Seroprotection rates (%) determined using HI assays after vaccination with MF59-adjuvanted and “plain” vaccines, according to viral strain.
Figure 2. Seroprotection rates (%) determined using HI assays after vaccination with virosome-adjuvanted and “plain” vaccines, according to viral strain.
Figure 3. Seroprotection rates (%) determined using HI assays after vaccination with intradermal and “plain” vaccines, according to viral strain.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.